Home › Cancer (all types) › Connecticut
Cancer (all types) clinical trials in Connecticut
46 studies for Cancer (all types) are looking for participants at sites in Connecticut.
Cities in Connecticut
- New Haven35 studies
- East Norwalk9 studies
- Hartford9 studies
- Bridgeport9 studies
- Norwalk5 studies
- Norwich5 studies
- North Stamford3 studies
Bexmarilimab + Azacitidine Versus Placebo + Azacitidine in Participants With Treatment-naïve Higher-risk Myelodysplastic Syndromes
- Yale Cancer Center, New Haven
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 13, 2026 · NCT07672769A Study of YL242 in Subjects With Advanced Solid Tumors
- US-201, New Haven
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT07197827Generating Novel Translational and Therapeutic Strategies Based on a Multicenter, Pediatric and AYA Evolutionary Tumor Board (pedsETB)
- Connecticut Children's Medical Center, Hartford
RecruitingObservational study
All ages · All sexes · Updated Nov 12, 2026 · NCT06423950Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- Danbury Hospital, Danbury
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield
- Smilow Cancer Hospital Care Center at Greenwich, Greenwich
- and 8 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 9, 2026 · NCT06580314A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
- Yale School of Medicine - Cedar Street, New Haven
RecruitingPhase 1
Ages 18 to 99 · All sexes · Updated Nov 5, 2026 · NCT07540572A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
- Hartford HealthCare - Hartford Hospital, Hartford
- Yale University School of Medicine, New Haven
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT06901531A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Yale University School of Medicine, New Haven
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT06119581A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
- Yale Cancer Center, New Haven
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT07578571Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
- Yale Cancer Center, New Haven
RecruitingPhase 2/3
All ages · All sexes · Updated Nov 2, 2026 · NCT03435796Visugromab in Cachexia International Trial
- Eastern Connecticut Hematology & Oncology, Norwich
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Nov 2, 2026 · NCT07112196A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
- Yale University School of Medicine /ID# 272447, New Haven
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 27, 2026 · NCT06953960Improving Communication Between AYA Oncology Patients and Clinicians: A Patient-Centered Intervention
- Connecticut Children's Medical Center, Hartford
Recruiting
Ages 15 to 25 · All sexes · Updated Oct 22, 2026 · NCT06982066A Study of ASP3082 in Adults With Advanced Solid Tumors
- Smilow Cancer Center at Yale New Haven Hospital, New Haven
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 14, 2026 · NCT05382559Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
- Yale University, Yale Cancer Center, New Haven
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 13, 2026 · NCT06993844FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Yale University School of Medicine, New Haven
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 7, 2026 · NCT05919264A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
- Yale New Haven Hospital ( Site 3012), New Haven
RecruitingPhase 1/2
1 Month – 17 Years · All sexes · Updated Oct 6, 2026 · NCT06941272A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)
- Smilow Cancer Hospital at Yale New Haven, New Haven
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06884618TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- Saint Vincent's Medical Center (SVMC), Bridgeport
- Hartford Hospital, Hartford
- Midstate Medical Center (MSMC), Meriden
- and 4 more
RecruitingPhase 2
Ages 12 and older · All sexes · Updated Sep 22, 2026 · NCT02693535Statins to Prevent Cancer Associated Blood Clots
- Yale University, New Haven
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT07303816Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance
- West Haven VA Medical Center, West Haven
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT05796375Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
- Smilow Cancer Hospital at Yale New Haven, New Haven
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT06072612Project: Every Child for Younger Patients With Cancer
- Connecticut Children's Medical Center, Hartford
- Yale University, New Haven
RecruitingObservational study
Up to age 25 · All sexes · Updated Aug 25, 2026 · NCT02402244Unified Network for Integrated Fluid Collection at Yale
- Smilow Cancer Hospital, New Haven
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 25, 2026 · NCT07689864A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies
- Yale- New Haven Hospital- Yale Cancer Center, New Haven
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 12, 2026 · NCT06759649A Study of ASP1002 in Adults for Treatment of Solid Tumors
- Yale University Cancer Center, New Haven
- Hartford HealthCare Cancer Institute at The Hospital of Central Connecticut, Plainville
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 23, 2026 · NCT05719558A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment Pumitamig (BNT327) and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer
- Yale University, New Haven
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jul 1, 2026 · NCT07079631Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
- VA Connecticut Healthcare System West Haven Campus, West Haven, CT, West Haven
Recruiting
Ages 18 to 75 · All sexes · Updated Jun 17, 2026 · NCT05486572Evaluation of a Mobile App Program for Coping With Cancer
- Smilow Cancer Hospital, New Haven
Recruiting
Ages 18 and older · All sexes · Updated Jun 15, 2026 · NCT06923501Light Therapy for Chemotherapy Induced Peripheral Neuropathy in Childhood Cancer Survivors
- Yale New Haven Health Smilow York Street Hospital, New Haven
- Yale New Haven Health Park Avenue Medical Center, Trumbull
Recruiting
Ages 5 and older · All sexes · Updated Jun 12, 2026 · NCT07019259Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
- Yale University School of Medicine /ID# 225707, New Haven
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jun 4, 2026 · NCT04777994A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)
- GSK Investigational Site, New Haven
RecruitingPhase 1
Ages 18 and older · All sexes · Updated May 22, 2026 · NCT06551142I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
- Yale Cancer Center, New Haven
RecruitingPhase 2
Ages 18 and older · All sexes · Updated May 6, 2026 · NCT01042379The Role of MicroRNA in the Diagnosis, Prognosis and Response to Treatment in Pancreatic Cancer
- Nuvance Health, Norwalk
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Apr 13, 2026 · NCT04406831A Pancreatic Cancer Screening Study in Individuals With New-Onset or Deteriorating Diabetes Mellitus
- Yale University, New Haven
- Nuvance Health, Norwalk
RecruitingObservational studyHealthy volunteers welcome
Ages 50 and older · All sexes · Updated Apr 13, 2026 · NCT03937453A Pancreatic Cancer Screening Study in Hereditary High Risk Individuals
- Nuvance Health, Norwalk
RecruitingObservational study
Ages 50 to 90 · All sexes · Updated Apr 13, 2026 · NCT03250078Life at 100.4: An Immersive Social Virtual Reality (VR) Education Tool for Adolescent and Young Adult Cancer Patients and Caregivers
- Pediatric Hematology/Oncology Clinic in Smilow Cancer Hospital, New Haven
Recruiting
Ages 13 to 39 · All sexes · Updated Feb 25, 2026 · NCT07224204TEMPUS ARIES: A Biobank Registry Platform Study in Oncology
- Eastern CT and Hematology and Oncology Associates, Norwich
RecruitingObservational study
Ages 18 to 99 · All sexes · Updated Feb 24, 2026 · NCT06207032GEMINI-NSCLC: NSCLC Biomarker Study
- Eastern CT and Hematology and Oncology Associates, Norwich
RecruitingObservational study
Ages 18 and older · All sexes · Updated Feb 5, 2026 · NCT05236114Beat Childhood Cancer Specimen Banking and Data Registry
- Connecticut Children's Hospital, Hartford
RecruitingObservational studyHealthy volunteers welcome
All ages · All sexes · Updated Feb 3, 2026 · NCT04715178SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Hartford
- Massive Bio SYNERGY-AI site, Norwalk
RecruitingObservational study
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.